Details for New Drug Application (NDA): 201942
✉ Email this page to a colleague
The generic ingredient in RASAGILINE MESYLATE is rasagiline mesylate. There are eighteen drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the rasagiline mesylate profile page.
Summary for 201942
Tradename: | RASAGILINE MESYLATE |
Applicant: | Carnegie |
Ingredient: | rasagiline mesylate |
Patents: | 0 |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | EQ 0.5MG BASE | ||||
Approval Date: | Nov 18, 2021 | TE: | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | EQ 1MG BASE | ||||
Approval Date: | Nov 18, 2021 | TE: | RLD: | No |
Complete Access Available with Subscription